Imbruvica Patient Assistance Program Transition Information

As of January 2nd, 2024, a new IMBRUVICA® Patient Assistance Program will be launched and administered by AbbVie. As a result, the Johnson & Johnson Patient Assistance Foundation (JJPAF) will no longer administer the IMBRUVICA® Patient Assistance program, and current enrollment in that program will close on December 29th, 2023.  

Patients who still need assistance in 2024 will need to complete an AbbVie Patient Assistance application and meet the program eligibility requirements.

• Imbruvica patients in the U.S. without insurance or those with limited coverage for our medicines may be eligible to receive Imbruvica at no cost to them through myAbbVie Assist.
• Patients can visit www.abbvie.com/IMBPAP after December 15th, 2023 for more information on how to apply.

Patients will be able to begin enrolling  no earlier than December 15^th, 2023.  AbbVie’s Patient Assistance Program begins on January 2, 2024.

Once all the necessary information needed is received, applications are usually reviewed within two business days. After that, contact with patients and their health care provider is made to inform them of application status.

Please visit www.abbvie.com/IMBPAP after December 15th for updated IMBRUVICA® information. 

The next step would be to visit www.abbvie.com/IMBPAP after December 15, 2023 to learn more about how you can apply to Imbruvica’s Patient Assistance Program.

If you have insurance, please review Independent Charitable Patient Assistance Programs (ICPAPs) that may be available and provide confirmation of denial or not available. ICPAPs are charitable organizations (often referred to as Co-Pay Foundations) that provide need based financial assistance to help patients obtain therapies prescribed or recommended by their Healthcare Provider.If you have commercial insurance, you can find out more about IMBRUVICA® By Your Side patient support and to see if you’re eligible for the IMBRUVICA® Copay Card . The program can be reached at 1-888-YourSide (1-888-968-7743).

If you qualify, you will receive free medicine for up to one year. At the end of your enrollment, you can re-apply for continued assistance.

It is free to apply, and those who qualify will received their medicine at no cost, including no copays or shipping costs.

Imbruvica provided through Imbruvica Patient Assistance is provided at no cost; including no co-pays or shipping costs.

• When completing the application, you have the option of allowing verification of income electronically.  If not, you will need to include your most recent Federal Tax Return for us to review.
• If you don’t have an income, please include a letter describing your current financial situation (e.g., unemployed, retired, etc.).

Once your application is reviewed, you and your health care provider will be notified about the results.

Please visit www.abbvie.com/IMBPAP after December 15th for IMBRUVICA® information.